139 related articles for article (PubMed ID: 37938177)
1. Exercise training adaptations in liver glycogen and glycerolipids require hepatic AMP-activated protein kinase in mice.
Hughey CC; Bracy DP; Rome FI; Goelzer M; Donahue EP; Viollet B; Foretz M; Wasserman DH
Am J Physiol Endocrinol Metab; 2024 Jan; 326(1):E14-E28. PubMed ID: 37938177
[TBL] [Abstract][Full Text] [Related]
2. Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice.
Hughey CC; James FD; Bracy DP; Donahue EP; Young JD; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2017 Dec; 292(49):20125-20140. PubMed ID: 29038293
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatic phosphoenolpyruvate carboxykinase 1 dysregulates metabolic responses to acute exercise but enhances adaptations to exercise training in mice.
Rome FI; Shobert GL; Voigt WC; Stagg DB; Puchalska P; Burgess SC; Crawford PA; Hughey CC
Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E9-E23. PubMed ID: 36351254
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
5. Elevated liver glycogenolysis mediates higher blood glucose during acute exercise in Barth syndrome.
Schweitzer GG; Ditzenberger GL; Hughey CC; Finck BN; Martino MR; Pacak CA; Byrne BJ; Cade WT
PLoS One; 2023; 18(8):e0290832. PubMed ID: 37651450
[TBL] [Abstract][Full Text] [Related]
6. Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism.
Hardie DG
Proc Nutr Soc; 2011 Feb; 70(1):92-9. PubMed ID: 21067629
[TBL] [Abstract][Full Text] [Related]
7. Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation.
Hasenour CM; Ridley DE; James FD; Hughey CC; Donahue EP; Viollet B; Foretz M; Young JD; Wasserman DH
PLoS One; 2017; 12(1):e0170382. PubMed ID: 28107516
[TBL] [Abstract][Full Text] [Related]
8. Hearts lacking plasma membrane K
Youssef N; Campbell S; Barr A; Gandhi M; Hunter B; Dolinsky V; Dyck JRB; Clanachan AS; Light PE
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H469-H478. PubMed ID: 28667052
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hepatic mitochondrial pyruvate and amino acid metabolism impairs gluconeogenesis and endurance exercise capacity in mice.
Martino MR; Habibi M; Ferguson D; Brookheart RT; Thyfault JP; Meyer GA; Lantier L; Hughey CC; Finck BN
Am J Physiol Endocrinol Metab; 2024 Apr; 326(4):E515-E527. PubMed ID: 38353639
[TBL] [Abstract][Full Text] [Related]
10. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.
Viollet B; Guigas B; Leclerc J; Hébrard S; Lantier L; Mounier R; Andreelli F; Foretz M
Acta Physiol (Oxf); 2009 May; 196(1):81-98. PubMed ID: 19245656
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glucose transport by the AMP-activated protein kinase.
Fujii N; Aschenbach WG; Musi N; Hirshman MF; Goodyear LJ
Proc Nutr Soc; 2004 May; 63(2):205-10. PubMed ID: 15294031
[TBL] [Abstract][Full Text] [Related]
12. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
[No Abstract] [Full Text] [Related]
13. Response of Liver Metabolic Pathways to Ketogenic Diet and Exercise Are Not Additive.
Huang TY; Goldsmith FR; Fuller SE; Simon J; Batdorf HM; Scott MC; Essajee NM; Brown JM; Burk DH; Morrison CD; Burke SJ; Collier JJ; Noland RC
Med Sci Sports Exerc; 2020 Jan; 52(1):37-48. PubMed ID: 31389908
[TBL] [Abstract][Full Text] [Related]
14. Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity.
Steinberg GR; O'Neill HM; Dzamko NL; Galic S; Naim T; Koopman R; Jørgensen SB; Honeyman J; Hewitt K; Chen ZP; Schertzer JD; Scott JW; Koentgen F; Lynch GS; Watt MJ; van Denderen BJ; Campbell DJ; Kemp BE
J Biol Chem; 2010 Nov; 285(48):37198-209. PubMed ID: 20855892
[TBL] [Abstract][Full Text] [Related]
15. AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity.
Lantier L; Fentz J; Mounier R; Leclerc J; Treebak JT; Pehmøller C; Sanz N; Sakakibara I; Saint-Amand E; Rimbaud S; Maire P; Marette A; Ventura-Clapier R; Ferry A; Wojtaszewski JF; Foretz M; Viollet B
FASEB J; 2014 Jul; 28(7):3211-24. PubMed ID: 24652947
[TBL] [Abstract][Full Text] [Related]
16. l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism.
Adachi Y; De Sousa-Coelho AL; Harata I; Aoun C; Weimer S; Shi X; Gonzalez Herrera KN; Takahashi H; Doherty C; Noguchi Y; Goodyear LJ; Haigis MC; Gerszten RE; Patti ME
Mol Metab; 2018 Nov; 17():61-70. PubMed ID: 30190193
[TBL] [Abstract][Full Text] [Related]
17. Modifying the Dietary Carbohydrate-to-Protein Ratio Alters the Postprandial Macronutrient Oxidation Pattern in Liver of AMPK-Deficient Mice.
Chalvon-Demersay T; Even PC; Chaumontet C; Piedcoq J; Viollet B; Gaudichon C; Tomé D; Foretz M; Azzout-Marniche D
J Nutr; 2017 Sep; 147(9):1669-1676. PubMed ID: 28747486
[No Abstract] [Full Text] [Related]
18. Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes.
Weightman Potter PG; Vlachaki Walker JM; Robb JL; Chilton JK; Williamson R; Randall AD; Ellacott KLJ; Beall C
Diabetologia; 2019 Jan; 62(1):187-198. PubMed ID: 30293112
[TBL] [Abstract][Full Text] [Related]
19. Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen.
McConell GK; Lee-Young RS; Chen ZP; Stepto NK; Huynh NN; Stephens TJ; Canny BJ; Kemp BE
J Physiol; 2005 Oct; 568(Pt 2):665-76. PubMed ID: 16051629
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of genistein on the production performance and lipid metabolism disorders in laying hens with fatty liver hemorrhagic syndrome by activation of the GPER-AMPK signaling pathways.
Li L; Wang Y; Wang H; Yang Y; Ma H
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37314978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
